세계의 팔꿈치관절 치환술 시장 : 시술 유형별, 최종사용자별, 지역별 - 성장, 동향, 예측(2018-2023년)
Elbow Replacement Market - Growth, Trends, and Forecasts (2022 - 2027)
세계의 팔꿈치관절 치환술 시장은 2018-2023년간 양호한 속도로 성장할 전망입니다. 팔꿈치관절 치환술은 부상된 부위를 제거하고 인공 관절로 치환하는 수술입니다. 주로 팔꿈치관절 류머티즘 환자에게 추천되는 치료법이지만, 상완골원위부 골절이나 기타 팔꿈치 부상과 같은 경우까지 확장될 수 있습니다.
세계의 팔꿈치관절 치환술(Elbow Replacement) 시장을 조사했으며, 시장 개요, 시술 유형·최종사용자·지역별 시장 동향, 시장 규모 추이와 예측, 시장 성장 촉진요인 및 저해요인, 시장 기회와 과제, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
The damaged parts of the elbow are replaced with artificial elbow devices through a surgery which is known as elbow replacement. The growth is mainly driven by technological advancements and the growing burden of diseases such as osteoarthritis and rheumatoid arthritis. Elbow replacement can also be extended to cases, such as distal humerus fractures, distal humerus nonunions, and other elbow injuries. Rheumatoid Arthritis (RA) is a chronic systemic disease that affects the joints, connective tissues, muscle, tendons, and fibrous tissue. According to John Hopkins Research, the prevalence of rheumatoid arthritis is 1% to 2% globally, and the important joints involve wrist and elbow. Furthermore, the global increase in the number of geriatrics is likely to lead to consequences, like greater incidences of chronic and life-threatening diseases. Thus, the increasing disease burden of arthritis is expected to drive the elbow replacement market.
Based on the product, it is segmented into partial elbow replacement and total elbow replacement. In total elbow replacement surgery, the damaged parts of the humerus and ulna are replaced with artificial components. The segment is anticipated to grow at a significant rate due to an increase in the number of patients, advancing technologies, and rising prevalence of arthritis. As per the Centers for Disease Control and Prevention (CDC), in 2014, around 54 million U.S. adults had doctor-diagnosed arthritis. Arthritis is the leading cause of disability, stiffness, and swelling of the joints, which usually occurs in older people, resulting in a high demand for elbow replacement surgeries. Pertaining to these factors, the market is expected to grow over the forecast period.
The elbow replacement market dominates North America due to a sedentary lifestyle, the growing burden of rheumatoid arthritis and elbow injuries. According to World Health Organization, the prevalence of rheumatoid arthritis varies between 0.3% and 1% and is more common in women and in developed countries. According to a study published in 2016, in the United States, there is an increase in the number of total elbow arthroplasty procedures performed per year, which is expected to drive the market growth. Furthermore, advanced technology, rise in awareness among people toward extremities implants, and developed healthcare infrastructure are estimated to propel the elbow replacement market in the region.
The global players into the elbow replacement market are Integra LifeSciences Corporation, Johnson & Johnson, Lima Corporate, Ottobock SE & Co. KGaA, Stryker Corporation, Wright Medical Group N.V. and Zimmer Biomet.